Get the Stockscreener App
10.29
5.76%
0.56
After Hours:
10.24
-0.05
-0.49%
Transcode Therapeutics Inc stock is traded at $10.29, with a volume of 9,103.
It is up +5.76% in the last 24 hours and down -10.52% over the past month.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
See More
Previous Close:
$9.73
Open:
$9.46
24h Volume:
9,103
Relative Volume:
0.26
Market Cap:
$8.58M
Revenue:
-
Net Income/Loss:
$-14.93M
P/E Ratio:
-0.0387
EPS:
-266.137
Net Cash Flow:
$-15.87M
1W Performance:
+0.00%
1M Performance:
-10.52%
6M Performance:
-81.44%
1Y Performance:
-95.77%
1-Day Range:
$9.46
$10.29
1-Week Range:
$9.2901
$10.29
52-Week Range:
$6.1478
$739.20
Transcode Therapeutics Inc Stock (RNAZ) Company Profile
Name
Transcode Therapeutics Inc
Sector
Industry
Phone
857-301-6857
Address
6 LIBERTY SQUARE, BOSTON
Compare RNAZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RNAZ
Transcode Therapeutics Inc
|
10.29 | 8.11M | 0 | -14.93M | -15.87M | -266.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
401.00 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.90 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.00 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
706.41 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.04 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Transcode Therapeutics Inc Stock (RNAZ) Latest News
TransCode Therapeutics shareholders approve all proposals at annual meeting - Investing.com
Dip Buying: Should value investors consider TransCode Therapeutics Inc.Weekly Trend Recap & Smart Investment Allocation Tips - خودرو بانک
Is TransCode Therapeutics Inc. still a buy after recent gains2025 Technical Overview & Technical Confirmation Alerts - خودرو بانک
TransCode Therapeutics Passes Key Proposals at Annual Meeting - TipRanks
Can TransCode Therapeutics Inc. outperform in the next rallyWeekly Profit Recap & Capital Efficient Trading Techniques - خودرو بانک
TransCode Therapeutics Inc. stock outlook for YEARDollar Strength & Free Real-Time Market Sentiment Alerts - Newser
What institutional flow reveals about TransCode Therapeutics Inc.July 2025 Trends & Community Consensus Trade Alerts - Newser
Will earnings trigger a reversal in Sharps Technology Inc. Equity WarrantEarnings Growth Summary & Weekly Hot Stock Watchlists - Newser
What the charts say about TMDX todayJuly 2025 Review & Low Risk High Win Rate Stock Picks - Newser
Real time social sentiment graph for TransCode Therapeutics Inc.July 2025 Big Picture & Growth Focused Stock Reports - Newser
Does TransCode Therapeutics Inc. show high probability of reboundCEO Change & Daily Entry Point Alerts - Newser
Is TransCode Therapeutics Inc. trading at a discountGDP Growth & AI Enhanced Trade Execution Alerts - خودرو بانک
What’s the beta of TransCode Therapeutics Inc. stockGap Down & Daily Growth Stock Tips - خودرو بانک
Is TransCode Therapeutics Inc. reversing from oversold territoryWeekly Trend Summary & Real-Time Stock Movement Alerts - Newser
Is TransCode Therapeutics Inc. a strong growth stockTreasury Yields & Detailed Earnings Play Alerts - خودرو بانک
Measuring TransCode Therapeutics Inc.’s beta against major indicesWatch List & Verified Momentum Stock Alerts - Newser
What’s the fair value of TransCode Therapeutics Inc. stockInflation Watch & Safe Capital Growth Stock Tips - خودرو بانک
What earnings revisions data tells us about TransCode Therapeutics Inc.Fed Meeting & Real-Time Volume Analysis Alerts - Newser
Trendlines Suggest TransCode Therapeutics Inc. May Bottom Out Soon getLinesFromResByArray error: size == 0 - thegnnews.com
What is AN2 Therapeutics Inc. s 5 year growth outlookWeekly Stock Analysis & Real-Time Volume Trigger Notifications - خودرو بانک
Is it time to cut losses on TransCode Therapeutics Inc.2025 Year in Review & Real-Time Stock Entry Alerts - Newser
What data driven models say about TransCode Therapeutics Inc.’s futureWeekly Trade Recap & Risk Controlled Swing Alerts - Newser
Long term hold vs stop loss in TransCode Therapeutics Inc.July 2025 Update & High Accuracy Swing Entry Alerts - Newser
Can momentum traders help lift TransCode Therapeutics Inc.Trade Volume Report & Capital Protection Trade Alerts - Newser
Will TransCode Therapeutics Inc. outperform the marketTrade Signal Summary & Free Accurate Trade Setup Notifications - Newser
How moving averages guide TransCode Therapeutics Inc. trading2025 Market Sentiment & Reliable Intraday Trade Alerts - Newser
Should you hold or exit TransCode Therapeutics Inc. nowMarket Sentiment Report & Low Risk Profit Maximizing Plans - Newser
Published on: 2025-08-30 14:49:28 - Newser
Is OnKure Therapeutics Inc. still worth holding after the dipPortfolio Performance Report & High Return Trade Guides - Newser
Signal strength of TransCode Therapeutics Inc. stock in tech scannersQuarterly Earnings Report & High Conviction Buy Zone Alerts - Newser
What’s next for TransCode Therapeutics Inc. stock priceWeekly Trading Summary & Free Weekly Watchlist of Top Performers - Newser
TransCode Therapeutics Inc. May Be Forming Higher Low — Chartwatchers Alert2025 Performance Recap & Safe Capital Investment Plans - beatles.ru
Transcode Therapeutics Inc Stock (RNAZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):